Thirteen patients (seven men, six women, mean age 49 ± 8 (SD) years, range 36–62) with a diagnosis of EOAG and 29 OHT patients (15 men and 14 women, mean age 48 ± 7 years, range: 28–57) were included in the study. In the patients with EOAG, intraocular pressure (IOP) measured by Goldman tonometry was more than 21 mm Hg on two or more occasions. These patients had an open-angle, abnormal white-on-white perimetry test result (Humphrey 30-2; Humphrey Field Analyzer; Carl Zeiss Meditec, Dublin, CA) with a typical reproducible defect. Two experienced glaucoma specialists (AC, TS) evaluated the optic discs independently by slit lamp biomicroscopy and 78-D lens. They were in full agreement on the pathologic disc abnormalities. These discs had a cup-to-disc ratio greater than 0.6 or an interocular cup-to-disc ratio asymmetry greater than or equal to 0.2. Furthermore, the discs had one or more of the following abnormalities: excavation, thinning of the rim, notching, nerve fiber layer defects, or peripapillary atrophy. Peripapillary atrophy, associated with excavation, and thinning of the rim was observed in one EOAG eye. The remaining EOAG eyes had several of the other disc abnormalities, which were confirmed by a semiautomated analysis performed by using confocal scanning laser ophthalmoscopy (described later). Field loss was graded from early to moderate in all patients, with Humphrey 30-2 mean deviation ranging 1.2 to 6 dB.
Patients with OHT had an elevated IOP (>21 mm Hg on two or more occasions), normal Humphrey perimetry results, and normal clinical optic disc appearance. In all patients, central corneal thickness, measured with a digital ultrasonic pachymeter (Altair; Optikon 2000, Rome, Italy) was between 520 and 570 μm. Sixteen normal subjects, whose sex and age distribution was comparable with that of the patients (mean age, 48 ± 6 years; range: 28–62), provided normative RFonh values. Only subjects and patients with excellent target fixation were entered into the study.
In 22 of 29 OHT patients and in 12 of 13 EOAG patients, analysis of the optic disc was also performed by confocal scanning laser ophthalmoscopy (Heidelberg Retina Tomograph, HRT; Heidelberg Engineering, Heidelberg, Germany) according to a previously published protocol.
14 The other 7 OHT patients and 1 with EOAG did not consent to this additional examination. Among the various morphometric parameters obtained by HRT, those most sensitive and specific for glaucoma damage
15 were considered in the analysis: the neuroretinal rim area, the cup-to-disc area ratio, and the cup shape measure. In addition, the retinal nerve fiber layer thickness and the rim volume data were measured in each study eye. These measurements were compared with the 95% confidence limits established in 16 normal eyes (mean age, 44 ± 7 years, range 38–59), with disc areas in the ranges 1 to 2 and 2 to 3 mm
2.
All patients underwent pattern electroretinogram (PERG) recordings according to a previously published technique.
16 17 Briefly, PERGs were recorded in response to sinusoidal gratings of variable spatial frequency (1.7 and 2.6 cyc/deg), modulated in counterphase at 7.5 Hz and presented on a high-resolution video monitor (56% contrast; 80 cd/m
2 mean luminance; 24° × 14° field size). The peak-to-peak amplitude of the response second harmonic (isolated by Fourier analysis) was measured. Results were compared with those obtained from 36 age- and sex-matched control subjects (mean age 46 ± 8 years, range, 32–58).
Subjects providing normative
RF
onh, HRT, and PERG data belonged to independent groups.
Table 1 summarizes demographic and clinical findings obtained in OHT and EOAG patients and in control subjects providing normative F
onh and
RF
onh data. At the time of testing, all the EOAG patients were under medical treatment (with topical β-blocker alone or in combination with dorzolamide or latanoprost). Of the 29 OHT patients, 16 were not under treatment, whereas the remaining 13 were under topical β-blocker alone or in combination with dorzolamide or latanoprost. IOPs at the time of testing did not differ significantly between patients with EOAG or OHT, as well as between untreated or treated patients with OHT (independent
t-test).
The study protocol was approved by the Ethics Committee of the Università Cattolica S. Cuore and followed the guidelines of the Declaration of Helsinki. Informed consent was obtained from every normal subject or patient after the procedures used in the study were fully explained.